- Prof. Yan-Jiang Wang
Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, China.
Website | E-mail
- Prof. Sheng Chen
Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Website | E-mail
Special Issue Introduction
COVID-19 patients experienced a wide range of symptoms that affect multiple organs and systems of the body. Neurological symptoms were extremely common, appearing in about 80% of patients who had been hospitalized with COVID-19. Furthermore, COVID-19 causes a variety of neurological sequelae in survivors, including cognitive deficits, dizziness, headache, myalgias, hypogeusia, hyposmia, polyneuropathy, myositis, cerebrovascular diseases, encephalitis, and encephalopathy et al. These long-term neurological outcomes dramatically threaten the quality of life in COVID-19 survivors. Recent research advances have identified the fact that even mild COVID-19 may cause irreversible microstructure damage in the brain, suggesting an intimate association between COVID-19 and brain disorders.
With the increasing amount of the population surviving COVID-19, the long-term neurological consequences should be concerned. Therefore, we launched this special issue to collect advances in the neurological consequences of COVID-19.
This special issue will welcome submissions including but not limited to:
● Clinical investigations about the neurological manifestations and/or sequelae of COVID-19
● Clinical investigations about the consequences of COVID-19 in subjects with neurological diseases
● Studies of the mechanism through which COVID-19 can damage the brain
● Preventative measures to reduce the negative implications in the brain associated with COVID-19
● Treatment of neurological disorders caused by COVID-19
● Opinions and Perspectives that focus on the impact of COVID-19 on the brain (This special issue solicits the submission of Opinion and Perspective articles on both animal and human models that provide editorialized analysis related to the scope of “COVID-19 and the brain” by established researchers in this area of expertise)
Potential Authors Lists:
● Yanling Ge, Department of Infectious Disease, Children's Hospital of Fudan University, Shanghai, China.
● Linamara Rizzo Batistella, Departamento de Medicina Legal, Etica Medica e Medicina Social e do Trabalho, Faculdade de Medicina da Universidade de São Paulo HCFMUSP, São Paulo, Brasil.
● Aayat Ellahi, Department of Internal Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
● Tirisham V Gyang, The Ohio State University, Columbus, OH, USA.
● L Hizmali, Kirsehir Ahi Evran University Faculty of Medicine, Department of Clinical Microbiology and Infectious Diseases, Kirsehir, Turkey.
● Ashkan Mowla, Division of Stroke and Endovascular Neurosurgery, Department of Neurological Surgery, Keck School of Medicine, University of Southern California, CA, USA.
● Elham Safarzadeh, Department of Microbiology, Parasitology, and Immunology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
● Luana Benedetti, IRCCS, Ospedale Policlinico San Martino, Genova, Italy.
● Xiang-Ru Wang, State Key Laboratory of Agricultural Microbiology, The Cooperative Innovation Center for Sustainable Pig Production, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, Hubei, China.
● Yulin Zhang, Department of Respiratory, Beijing Youan Hospital, Capital Medical University, Beijing, China.
COVID-19, SARS-CoV-2, brain, neurology
Submission Deadline15 Dec 2022